Brilacidin First-in-Class Defensin-Mimetic Drug Candidate https://mcusercontent.com/9ed1a6b082ae8962468007971/files/b1f1cf16-3bf8-469d-8620-74e5f423b79a/IPIX_Brilacidin_Defensin_Mimetics_COVID_19_Overview_Feb_2020_fv_2_.pdf Background and Scientific Rationale for Brilacidin as a Potential Novel Coronavirus (COVID-19) Treatment